29 August 2011
According to a new Danish study, women who begin using multivitamin supplements around the time of conception may have a lower risk of giving birth prematurely.
In the observational study, 35,897 women participating in the Danish National Birth Cohort were evaluated regarding the occurrence of premature birth – defined as birth prior to the 37th week of pregnancy – and multivitamin use during a 12-week period around the time of conception (1). The study results showed that normal-weight regular users of multivitamins taking supplements for four to six weeks around the period of conception had a significantly reduced risk of pre-term labor and premature birth. No benefits were observed in overweight women. The supplements contained folic acid (200 µg), vitamins Cand E, as well as zinc.
The researchers concluded that multivitamin use around the time of conception could be a safe and simple strategy to improve pregnancy outcomes. However, the results should be interpreted with caution because pregnancy outcomes can also be linked to other lifestyle factors. Zinc, and antioxidant vitamins C and E have previously been associated with the risk of pre-term birth. Pre-term birth may be related to the impact of oxidative stress on the placenta.
1 February 2015
People living in northern latitudes may have an increased risk of developing dementia due to the reduced ability to make vitamin D from the limited sunlight suggests a new UK study.
3 December 2015
A new paper using data from the DIAMOND (DHA Intake And Measurement Of Neural Development) study has shown that supplementation of infant formula with docosahexaenoic acid (DHA) and arachidonic acid (ARA) during the first year of life has a protective effect against allergy in early childhood. The allergy status of the mother was shown to have a profound effect on the nature of the protection for the infant.
31 December 2008
“It is surprising how difficult it has been to develop widely acceptable data relating diet and chronic disease. In spite of epidemiological and animal studies supporting many of these relationships, focused human clinical studies have often been negative or at best equivocal. There is no good explanation for this.”
